SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-030939
Filing Date
2018-12-13
Accepted
2018-12-13 18:31:59
Documents
2
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1560
2 EX-24 DOCUMENT attachment1.htm EX-24 3765
  Complete submission text file 0000899243-18-030939.txt   6671
Mailing Address C/O KERYX BIOPHARMACEUTICALS INC ONE MARINA PARK DRIVE BOSTON MA 02210
Business Address
ROGERS MICHAEL W (Reporting) CIK: 0001244159 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 181234213

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences